Abstract:Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a leading cause of cancer-related deaths, with conventional treatments offering limited effectiveness in advanced stages, due to distant metastases and treatment resistance. Recent advancements in immunotherapy, specifically immune checkpoint inhibitors (ICIs), have shown promise, but their efficacy as standalone therapies are often insufficient. This has led to increased interest in combining ICIs with radiotherapy, known as radioimmunotherapy (iRT), to enhance treatment outcomes. This review explores the mechanisms that underlie the synergy between radiotherapy and immunotherapy. Radiotherapy can induce the "abscopal effect", eliciting systemic immune responses that reduce tumor burdens outside the treated area. It also increases the expression of major histocompatibility complex class I (MHC-I) on tumor cells, improving immune recognition. Furthermore, radiotherapy can modify the tumor microenvironment by inducing metabolic reprogramming to bolster anti-tumor immunity. We discuss strategies for optimizing iRT, including considerations of radiation doses, fractionation schedules, and treatment site selection, which significantly influence immune responses by enhancing MHC-I expression or promoting T-cell infiltration. Clinical evidence supports the efficacy of iRT in NSCLC and other cancers, though challenges in standardizing treatment protocols and managing side effects persist. Overall, radioimmunotherapy presents a promising approach to improving NSCLC treatment outcomes. Ongoing research into its mechanisms and the refinement of treatment may reshape clinical practice, offering more effective and personalized options for patients with advanced lung cancer. Further studies are essential to validate these findings and optimize therapeutic protocols.

Mechanisms and progress of radiotherapy plus immunotherapy treating malignant tumors

Research Advances in Mechanisms for Combination Therapy with Stereotactic Body Radiation Therapy and Immunotherapy

The Intersection of Radiotherapy and Immunotherapy: Mechanisms and Clinical Implications.

The Immune Effect of Radiotherapy on Tumor

Research Advances in Radiotherapy Combined with Immunotherapy for Cancer

Radiotherapy and Immunotherapy: a Beneficial Liaison?

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

The Reciprocity Between Radiotherapy and Cancer Immunotherapy

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment

Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects

Synergistic Effects of Acoustics-based Therapy and Immunotherapy in Cancer Treatment

Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade

Biological foundation and research progress on radiotherapy combined with immuno-therapy

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions

A new target of radiotherapy combined with immunotherapy: regulatory T cells

Recent progress in the combination treatment of radiotherapy and PD-1/PD-L1 signaling blockade immunotherapy

Radioimmunotherapy: a game-changer for advanced non-small cell lung cancer

Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies

Combined use of NK cells and radiotherapy in the treatment of solid tumors

Radiotherapy Assisted with Biomaterials to Trigger Antitumor Immunity

Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment